Clinical, genetic and environmental influences on weight gain and metabolic disorders induced by psychotropic drugs

por Eap, C.
Publicado 2022

Weight gain and metabolic disorders induced by psychotropic drugs: an appraisal of risk factors

por Eap, C. B.
Publicado 2023

CYP2C19 expression modulates affective functioning and brain anatomy – a large single-center community-dwelling cohort study

por Grosu, C., Trofimova, O., Gholam, M., Strippoli, M.-P., Kherif, F., Lutti, A., Preisig, M., Draganski, B., Eap, C.
Publicado 2022

Effects of psychotropic switches on weight change: a prospective cohort study

por Piras, M., Ranjbar, S., Dubath, C., Laaboub, N., Grosu, C., Gamma, F., Von Plessen, K., Von Gunten, A., Conus, P., Eap, C.
Publicado 2022

Metabolic disturbances are associated with psychiatric readmission: results from a Swiss psychiatric cohort

por Laaboub, N., Gholam, M., Dubath, C., Grosu, C., Piras, M., Von Plessen, K., Von Gunten, A., Conus, P., Preisig, M., Eap, C.
Publicado 2022

An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis

por Perry, B., Vandenberghe, F., Osimo, E.F., Grosu, C., Piras, M., Jones, P., Mallikarjun, P., Stochl, J., Upthegrove, R., Khandaker, G., Eap, C.
Publicado 2022

DNA methylation may mediate psychotropic drug-induced metabolic side effects: results from a 1-month observational study

por Dubath, C., Porcu, E., Delacrétaz, A., Grosu, C., Laaboub, N., Piras, M., Von Gunten, A., Conus, P., Von Plessen, K., Kutalik, Z., Eap, C.
Publicado 2022